Induced pluripotent stem cells: a novel frontier in the study of human primary immunodeficiencies.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Allergy and Clinical Immunology

• Publication date

  2011-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jaci.2010.11.008PMID 21185069PMCID PMC3081993
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differentiation of induced pluripotent stem cells to thymic epithelial cells by phenotype

  2011cited by this paper
• Chromosome 22q11.2 Deletion Syndrome (DiGeorge Syndrome/Velocardiofacial Syndrome)

  2011cited by this paper
• Generation of functional gut-like organ from mouse induced pluripotent stem cells.

  2010cited by this paper
• Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency

  2010cited by this paper
• Primary immunodeficiencies associated with DNA-repair disorders

  2010cited by this paper
• Eliciting the T cell fate with Notch.

  2010cited by this paper
• Efficient Generation of Functional Dopaminergic Neurons from Human Induced Pluripotent Stem Cells Under Defined Conditions

  2010cited by this paper
• Progress toward the clinical application of patient-specific pluripotent stem cells.

  2010cited by this paper
• Positive selection of T cells, an in vitro view.

  2010cited by this paper
• Dopaminergic Neurons Derived from Human Induced Pluripotent Stem Cells Survive and Integrate into 6-OHDA-Lesioned Rats

  2010cited by this paper
• Reprogramming of human peripheral blood cells to induced pluripotent stem cells.

  2010cited by this paper
• Primary immunodeficiencies.

  2010cited by this paper
• Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells

  2010cited by this paper
• Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis.

  2010cited by this paper
• Human motor neuron generation from embryonic stem cells and induced pluripotent stem cells

  2010cited by this paper
• Generation of Transgene‐Free Lung Disease‐Specific Human Induced Pluripotent Stem Cells Using a Single Excisable Lentiviral Stem Cell Cassette

  2010cited by this paper
• Generation of murine hepatic lineage cells from induced pluripotent stem cells.

  2010cited by this paper
• Defect of regulatory T cells in patients with Omenn syndrome.

  2010cited by this paper
• Derivation of neural crest cells from human pluripotent stem cells

  2010cited by this paper
• The first reported generation of human induced pluripotent stem cells (iPS cells) and iPS cell-derived cardiomyocytes in the Netherlands.

  2010cited by this paper
• Direct Comparison of Dll1- and Dll4-Mediated Notch Activation Levels Shows Differential Lymphomyeloid Lineage Commitment Outcomes

  2010cited by this paper
• Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage

  2009cited by this paper
• Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells

  2009cited by this paper
• Modeling Pathogenesis and Treatment of Familial Dysautonomia using Patient Specific iPSCs

  2009cited by this paper
• New insights into the pathogenesis of adenosine deaminase-severe combined immunodeficiency and progress in gene therapy

  2009cited by this paper
• Induced Pluripotent Stem Cell Generation Using a Single Lentiviral Stem Cell Cassette

  2009cited by this paper
• Phenotypic correction of murine hemophilia A using an iPS cell-based therapy

  2009cited by this paper
• Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling

  2009cited by this paper
• Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells

  2009cited by this paper
• Induced human pluripotent stem cells: promises and open questions

  2009cited by this paper
• Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells

  2009cited by this paper
• Excision of Reprogramming Transgenes Improves the Differentiation Potential of iPS Cells Generated with a Single Excisable Vector

  2009cited by this paper
• Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells

  2009cited by this paper
• Differentiation of murine embryonic stem and induced pluripotent stem cells to renal lineage in vitro.

  2009cited by this paper
• Hematopoietic Development from Human Induced Pluripotent Stem Cells

  2009cited by this paper
• Recent Advances in Primary Immunodeficiencies: Identification of Novel Genetic Defects and Unanticipated Phenotypes

  2009cited by this paper
• Generation of functional hepatocytes from mouse induced pluripotent stem cells

  2009cited by this paper
• Differentiation of human embryonic stem cells into osteogenic or hematopoietic lineages: A dose‐dependent effect of osterix over‐expression

  2009cited by this paper
• Primary immunodeficiencies: 2009 update.

  2009cited by this paper
• T lineage differentiation from induced pluripotent stem cells.

  2009cited by this paper
• Hematopoietic and Endothelial Differentiation of Human Induced Pluripotent Stem Cells

  2009cited by this paper
• Derivation of Functional Retinal Pigmented Epithelium from Induced Pluripotent Stem Cells

  2009cited by this paper
• Primary Immunodeficiencies

  2008cited by this paper
• Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons

  2008cited by this paper
• Chromosome 22q11.2 deletion syndrome: DiGeorge syndrome/velocardiofacial Syndrome.

  2008cited by this paper
• Generation of human-induced pluripotent stem cells

  2008influential reference
• Reprogramming of human somatic cells to pluripotency with defined factors

  2008influential reference
• Generation of human induced pluripotent stem cells from dermal fibroblasts

  2008cited by this paper
• The promise of human induced pluripotent stem cells for research and therapy

  2008cited by this paper
• Disease-specific induced pluripotent stem cells.

  2008cited by this paper
• Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity.

  2008cited by this paper
• Derivation and maintenance of human embryonic stem cells from poor-quality in vitro fertilization embryos

  2008cited by this paper
• Cartilage-hair hypoplasia: molecular basis and heterogeneity of the immunological phenotype

  2008cited by this paper
• TLR3 Deficiency in Patients with Herpes Simplex Encephalitis

  2007cited by this paper
• Treatment of Sickle Cell Anemia Mouse Model with iPS Cells Generated from Autologous Skin

  2007cited by this paper
• STAT3 mutations in the hyper-IgE syndrome.

  2007cited by this paper
• Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome

  2007cited by this paper
• Human Complete Stat-1 Deficiency Is Associated with Defective Type I and II IFN Responses In Vitro but Immunity to Some Low Virulence Viruses In Vivo1

  2006cited by this paper
• Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

  2006cited by this paper
• Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer

  2006cited by this paper
• Herpes Simplex Virus Encephalitis in Human UNC-93B Deficiency

  2006cited by this paper
• Karyotype of human ES cells during extended culture

  2004cited by this paper
• Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells

  2004cited by this paper
• Immunol. Cell Biol.

  1995cited by this paper

• Purine nucleoside phosphorylase deficiency induces p53-mediated intrinsic apoptosis in human induced pluripotent stem cell-derived neurons

  2022cites this paper
• A Research-Driven Approach to the Identification of Novel Natural Killer Cell Deficiencies Affecting Cytotoxic Function.

  2020cites this paper
• Treating primary immunodeficiencies with defects in NK cells: from stem cell therapy to gene editing

  2020cites this paper
• Establishment and characterization of induced pluripotent stem cells (iPSCs) from central nervous system lupus erythematosus

  2019cites this paper
• Title Robust and Highly-Efficient Differentiation of Functional Monocytic Cells from Human Pluripotent Stem Cells

  2018cites this paper
• Disease modeling of immunological disorders using induced pluripotent stem cells

  2018cites this paper
• Hematopoietic Cell Engineering From Human Pluripotent Stem Cells

  2017cites this paper
• Site-specific genome editing for hematopoetic stem cells transplantation-based gene therapy approaches

  2016cites this paper
• Exome and genome sequencing for inborn errors of immunity.

  2016cites this paper
• hiPSC‐derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine

  2016cites this paper
• HEMATOPOIESIS AND STEM CELLS Modeling altered T-cell development with induced pluripotent stem cells from patients with RAG1 -dependent immune de fi ciencies

  2016cites this paper
• Flow Cytometry, a Versatile Tool for Diagnosis and Monitoring of Primary Immunodeficiencies

  2016cites this paper
• Modeling altered T-cell development with induced pluripotent stem cells from patients with RAG1-dependent immune deficiencies.

  2016cites this paper
• Integrated analysis of mRNA, microRNA and protein in systemic lupus erythematosus-specific induced pluripotent stem cells from urine

  2016cites this paper
• Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells

  2015cites this paper
• Novel Genome-Editing Tools to Model and Correct Primary Immunodeficiencies

  2015cites this paper
• The Hope for iPSC in Lung Stem Cell Therapy and Disease Modeling

  2015cites this paper
• An Introduction to Cellular Reprogramming: The Plasticity of Cell Fates and Identities

  2014cites this paper
• Differential role of nonhomologous end joining factors in the generation, DNA damage response, and myeloid differentiation of human induced pluripotent stem cells

  2014cites this paper
• A glance on recent progresses in diagnosis and treatment of primary immunodeficiencies/ Progrese recente în diagnosticul şi tratamentul imunodeficienţelor primare

  2014cites this paper
• How Primary Immunodeficiencies Have Made Gene Therapy a Reality

  2014cites this paper
• iPSC for Dental Tissue Regeneration

  2014cites this paper
• Patient-specific induced pluripotent stem cell models in mitochondrial diseases.

  2014cites this paper
• Embryonic Stem Cells and Induced Pluripotent Stem Cells for Skeletal Regeneration

  2013cites this paper
• Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status

  2013cites this paper
• INVESTIGATING THE ROLES OF THE p63 ISOFORMS IN THE MICRORNA BIOGENESIS PATHWAY

  2013cites this paper
• Gene therapy for PIDs: Progress, pitfalls and prospects

  2013cites this paper
• Robust and Highly-Efficient Differentiation of Functional Monocytic Cells from Human Pluripotent Stem Cells under Serum- and Feeder Cell-Free Conditions

  2013cites this paper
• Patient-Specific Pluripotent Stem Cells

  2013cites this paper
• Leukocyte adhesion deficiencies

  2012cites this paper
• Disease-associated iPS cell lines representing hematological and immunological disorders

  2012cites this paper
• Induced pluripotent stem cells in research and therapy.

  2012cites this paper
• The Promise of Human Induced Pluripotent Stem Cells in Dental Research

  2012cites this paper
• Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells

  2012cites this paper
• Development of nuclease-mediated site-specific genome modification.

  2012cites this paper
• Advances in basic and clinical immunology in 2011.

  2012cites this paper
• Advances in Induced Pluripotent Stem Cell Technologies

  2012cites this paper
• The role of induced pluripotent stem cells in research and therapy of primary immunodeficiencies.

  2012cites this paper
• Correcting CGD safely, iPSo facto.

  2011cites this paper
• Induced pluripotent stem cells and primary immunodeficiencies: a new frontier reached, a new world beyond?

  2011cites this paper
• Immunological applications of stem cells in type 1 diabetes.

  2011cites this paper
• Primary immunodeficiency modeling with induced pluripotent stem cells

  2011cites this paper
• CGD safely, iPSo facto

  2011cites this paper
• Gene therapy for primary immunodeficiencies: looking ahead, toward gene correction.

  2011cites this paper
• Homologous recombination‐based gene therapy for the primary immunodeficiencies

  2011cites this paper
• Induced pluripotent stem cells as a next-generation biomedical interface

  2011cites this paper
• Dopaminergic Neurons Derived from Human Induced Pluripotent Stem Cells Survive and Integrate into 6-OHDA-Lesioned Rats

  2010cites this paper